Rocket Companies $1.8 billion IPO and NYSE listing
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket Companies, Inc. of 100,000,000 shares of Rocket Companies’ Class…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Graham Packaging $510 million notes offering and $1.5 billion credit facility
Davis Polk advised Graham Packaging Company Inc. on a Rule 144A/Regulation S offering of $510 million aggregate principal amount of its 7.125% senior notes due 2028. The notes are…
BioXcel Therapeutics $200 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…
Lennox International $600 million senior notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Lennox International Inc. of $300…
Spectrum Brands $300 million notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A and Regulation S offering by Spectrum Brands of $300 million aggregate principal amount…
ExxonMobil €4.5 billion notes offering
Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of €1.5 billion principal amount of 0.142% notes due 2024, €1 billion principal amount of 0.524% notes due 2028, €1…
Uniti Group $250 million at-the-market stock offering
Davis Polk advised Uniti Group Inc., as issuer, in connection with a new SEC-registered at-the-market offering program by Uniti under which Uniti may issue and sell shares of its common…
Generation Bio $230 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering of 12,105,263 shares of common stock of Generation Bio Co., which…
Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…
Applied Materials $1.5 billion notes offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Applied Materials, Inc. of $750 million aggregate principal amount of its 1.750% notes due 2030 and $750…